Volume 5, Issue 2, March 2019, Page: 26-32
α1-adrenergic Receptor Attenuates β1-adrenergic Modulation of IKr by Protein Kinase C-dependent Suppression of Adenylyl Cyclase in Ventricular Myocytes
Sen Wang, Department of Geriatric Cardiology, First Affiliated Hospital of Nanjing Medical University, Nanjing, China
Xiaoyan Wang, Department of Geriatric Cardiology, First Affiliated Hospital of Nanjing Medical University, Nanjing, China
Jin Qian, Department of Geriatric Cardiology, First Affiliated Hospital of Nanjing Medical University, Nanjing, China
Di Xu, Department of Geriatric Cardiology, First Affiliated Hospital of Nanjing Medical University, Nanjing, China
Received: May 8, 2019;       Accepted: Jun. 10, 2019;       Published: Jun. 25, 2019
DOI: 10.11648/j.ijcems.20190502.11      View  475      Downloads  58
The rapid delayed rectifier K+ current (Ikr) is critical for repolarization of the cardiac action potential. Previous studies have shown activated α1-adrenergic receptor (AR) attenuates β1-adrenergic regulation of Ikr while the mechanisms involved are poorly understood. To evalutate how α1-adrenergic receptor affect β1-adrenergic modulation of Ikr, whole-cell patch-clamp recordings were peformed in isolated guinea-pig ventricular myocytes. Application of xamoterol, a selective β1-AR agonist, induced a negative shift in the activation curve and Ikr current reduction by 40.50±6.66% at the test pulse of +40 mV. Forskolin and 8-Br-cAMP also resulted in Ikr reduction by 38.17±1.50% and 24.65±3.37%, respectively. Phenylephrine, a selective α1-AR agonist, prevented the activation shift and Ikr current reduction induced by xamoterol and forskolin, but not by 8-Br-cAMP. The effect of xamoterol or forskolin on Ikr was also prevented by pretreatment with PDBu, a protein kinase C (PKC) activator, while the effect of cAMP on Ikr can not, which was similar to pretreatment with phenylephrine. When cells were pretreated with chelerythrine, a specific PKC inhibitor, phenylephrine failed to prevent Ikr reduction induced by xamoterol. Our data suggests that α1-adrenergic stimulation attenuates β1-adrenergic regulation of Ikr, through PKC-dependent downregulation of adenylyl cyclase/cyclic AMP pathway.
Adrenergic Receptors, Ikr, Cross-talk, Protein Kinase C, Adenylyl Cyclase
To cite this article
Sen Wang, Xiaoyan Wang, Jin Qian, Di Xu, α1-adrenergic Receptor Attenuates β1-adrenergic Modulation of IKr by Protein Kinase C-dependent Suppression of Adenylyl Cyclase in Ventricular Myocytes, International Journal of Clinical and Experimental Medical Sciences. Vol. 5, No. 2, 2019, pp. 26-32. doi: 10.11648/j.ijcems.20190502.11
Copyright © 2019 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Sanguinetti MC, Jiang C, Curran ME and Keating MT A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel Cell Vol81, No2, 1995, pp 299-307.
Trudeau MC, Warmke JW, Ganetzky B and Robertson GA HERG, a human inward rectifier in the voltage-gated potassium channel family Science Vol269, No5220, 1995, pp 92-95.
Sanguinetti MC and Tristani-Firouzi M hERG potassium channels and cardiac arrhythmia Nature Vol 440, No 7083, 2006, pp 463-469.
Ficker E, Thomas D, Viswanathan PC, Dennis AT, Priori SG, Napolitano C, Memmi M, Wible BA, Kaufman ES, Iyengar S, Schwartz PJ, Rudy Y and Brown AM Novel characteristics of a misprocessed mutant HERG channel linked to hereditary long QT syndrome Am J Physiol Vol 279, No 4, 2000, pp H1748–H1756.
Thomas D, Kiehn J, Katus HA and Karle CA Defective protein trafficking in hERG-associated hereditary long QT syndrome (LQT2): Molecular mechanisms and restoration of intracellular protein processing Cardiovasc Res Vol 60, No 2, 2003, pp 239–245.
Thomas D, Karle CA and Kiehn J The cardiac hERG/IKr potassium channel as pharmacological target: structure, function, regulation, and clinical applications Curr Pharm Des Vol 12, No 8, 2006, pp 2271-2283.
Vandenberg JI, Perry MD, Perrin MJ, Mann SA, Ke Y and Hill AP hERG K (+) channels: structure, function, and clinical significance Physiol Rev Vol 92, No 3, 2012, pp 1393-1478.
Chae YJ, Lee HJ, Jeon JH, Kim IB, Choi JS, Sung KW and Hahn SJ Effects of donepezil on hERG potassium channels Brain Res Vol 1597, 2015, pp 77-85.
Li G, Shi R, Wu J, Han W, Zhang A, Cheng G, Xue X and Sun C Association of the hERG mutation with long‑QT syndrome type 2, syncope and epilepsy Mol Med Rep Vol 13, No 3, 2016, pp 2467-2475.
Zhang YH, Cheng H, Alexeenko VA, Dempsey CE, Hancox JC Characterization of recombinant hERG K+ channel inhibition by the active metabolite of amiodarone desethyl-amiodarone J Electrocardiol Vol 43, No5, 2010, pp 440-8.
Brodde OE and Michel MC Adrenergic and muscarinic receptors in the human heart Pharmacol Rev Vol 51, No 4, 1999, pp 651–689.
Karle CA, Zitron E, Zhang, W, Kathofer S, Schoels W and Kiehn J Rapid component IKr of the guinea-pig cardiac delayed rectifier K+ current is inhibited by β1-adrenoreceptor activation, via cAMP/protein kinase A-dependent pathways Cardiovasc Res Vol 53, No 2, 2002, pp 355–362.
Thomas D, Zhang W, Karle CA, Kathofer S, Schols W, Kubler W and Kiehn J Deletion of protein kinase A phosphorylation sites in the hERG potassium channel inhibits activation shift by protein kinase A J Biol Chem Vol 274, No 39, 1999, pp27457–27462.
Zankov DP, Yoshida H, Tsuji K, Toyoda F, Ding WG, Matsuura H and Horie M Adrenergic regulation of the rapid component of delayed rectifier K+ current: Implications for arrhythmogenesis in LQT2 patients Heart Rhythm Vol 6, No 7, 2009, pp 1038–1046.
Thomas D, Wu K, Wimmer AB, Zitron E, Hammerling BC, Kathofer S, Lueck S, Bloehs R, Kreye VA and Kiehn J Activation of cardiac human ether-a-go-go related gene potassium currents is regulated by α1A-adrenoceptors J Mol Med Vol 82, No 12, 2004, pp 826–837.
Urrutia J, Alday A, Gallego M, Malagueta-Vieira LL, Aréchiga-Figueroa IA, Casis O and Sánchez-Chapula JA Mechanisms of IhERG/IKr Modulation by α1-Adrenoceptors in HEK293 Cells and Cardiac Myocytes Cell Physiol Biochem Vol 40, No 6, 2016, pp 1261-1273.
Thomas D, Kiehn J, Katus HA and Karle CA Adrenergic regulation of the rapid component of the cardiac delayed rectifier potassium current, I (Kr), and the underlying hERG ion channel Basic Res Cardiol Vol 99, No 4, 2004, pp 279–287.
Wang S, Xu DJ, Cai JB, Huang YZ, Zou JG and Cao KJ Rapid component IKr of cardiac delayed rectifier potassium currents in guinea-pig is inhibited by α1-adrenoreceptor activation via protein kinase A and protein kinase C-dependent pathways Eur J Pharmacol Vol 608, No 1-3, 2009, pp 1-6.
Xu D, Wang S, Wu TT, Wang XY, Qian J and Guo Y Functional cross-talk between the α1- and β1-adrenergic receptors modulates the rapidly activating delayed rectifier potassium current in guinea pig ventricular myocytes Int J Mol Sci Vol 15, No 9, 2014, pp 14220-14233.
Marx SO, Kurokawa J, Reiken S, Motoike H, D'Armiento J, Marks AR and Kass RS Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel Science Vol 295, No 5554, 2002, pp 496-499.
Harmati G, Bányász T, Bárándi L, Szentandrássy N, Horváth B, Szabó G, Szentmiklósi JA, Szénási G, Nánási PP and Magyar J Effects of β-adrenoceptor stimulation on delayed rectifier K (+) currents in canine ventricular cardiomyocytes Br J Pharmacol Vol 162, No 4, 2011, pp 890-896.
Li GR, Feng J, Wang Z and Fermini, B Adrenergic modulation of ultrarapid delayed rectifier K+ current in human atrial myocytes Circ Res Vol 78, No 5, 1996, pp 903-915.
Koumi S, Backer CL, Arentzen CE and Sato R Beta-Adrenergic modulation of the inwardly rectifying potassium channel in isolated human ventricularmyocytes Alteration in channel response to beta-adrenergic stimulation in failing human hearts J Clin Invest Vol 96, No 6, 1995, pp 2870-2881.
Gallego M, Alday A, Alonso H and Casis O Adrenergic regulation of cardiac ionic channels: role of membrane microdomains in the regulation of kv4 channels Biochim Biophys Acta Vol 1838, No 2, 2014, pp 692-699.
Gallego M, Setién R, Puebla L, Boyano-Adánez MC, Arilla E and Casis O alpha1-Adrenoceptors stimulate a Galphas protein and reduce the transient outward K+ current via a cAMP/PKA-mediated pathway in the rat heart Am J Physiol Cell Physiol Vol 288, No 3, 2005, pp C577–C585
Wu TT, Wang S, Zou JG, Cao KJ and Xu D Cross effect of acute adrenergic stimulation on rapid component of delayed rectifier potassium channel current in guinea pig left ventriculare myocytes Chin J Cardiac Arrhyth Vol 2, 2014, pp 146-152.
Middleton LM and Harvey RD PKC regulation of cardiac CFTR Cl- channel function in guinea pig ventricular myocytes Am J Physiol Vol275, No 1, 1998, pp C293-C302.
Li L, Cai H, Liu H and Guo T β-Adrenergic stimulation activates protein kinase Cε and induces extracellular signal-regulated kinase phosphorylation and cardiomyocyte hypertrophy Mol Med Rep Vol 11, No, 2015, pp 4373-4380.
Yue Y, Qu Y and Boutjdir M Beta- and alpha-adrenergic cross-signaling for L-type Ca current is impaired in transgenic mice with constitutive activation of epsilonPKC Biochem Biophys Res Commun Vol 314, No 3, 2004, pp 749-754.
Guimond J, Mamarbachi AM, Allen BG, Rindt H and Hébert TE Role of specific protein kinase C isoforms in modulation of beta1- and beta2-adrenergic receptors Cell Signal Vol 17, No 1, 2005, pp 49-58.
Lai HL, Yang TH, Messing RO, Ching YH, Lin SC and Chern Y Protein kinase C inhibits adenylyl cyclase type VI activity during desensitization of the A2a-adenosine receptor-mediated cAMP response Journal of Biological Chemistry Vol 272, No 8, 1997, pp 4970-4977.
Boutjdir M, Restivo M, Wei Y and el-Sherif N Alpha1- and beta-adrenergic interactions on L-type calcium current in cardiac myocytes Pfluigers Archiv Vol 421, No 4, 1992, pp 397-399.
Barrett S, Honbo N and Karliner JS Alpha1-adrenoceptor-mediated inhibition of cellular cAMP accumulation in neonatal rat ventricular myocytes Naunyn Schmiedebergs Arch Pharmacol Vol 347, No, 1993, pp 384-393.
Pollard CE, Abi Gerges N, Bridgland-Taylor MH, Easter A, Hammond TG and Valentin JP An introduction to QT interval prolongation and non-clinical approaches to assessing and reducing risk Br J Pharmacol 2010; Vol 159, No, 2010, pp 12-21.
Rain C and Rada G Is carvedilol better than other beta-blockers for heart failure? Medwave 2015; 15 Suppl 1: e6168.
Browse journals by subject